Lawyers USA has ceased publication. If you have purchased a research pass or still have additional time on your current Digital Subscription, you may access locked stories by logging in.
Pfizer faces first trial on Neurontin suicide claim
Pfizer, Inc., the world’s biggest drugmaker, goes to trial today on claims its epilepsy medication Neurontin increases the risk of suicide, in a case the judge called “very tough” for the plaintiffs to win. The trial will be the first of what plaintiffs’ lawyers say are about 1,200 cases.